Opendata, web and dolomites

QS Mobile

Setting a standard for personal digital sperm analysis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 QS Mobile project word cloud

Explore the words cloud of the QS Mobile project. It provides you a very rough idea of what is the project "QS Mobile" about.

performing    children    manufacturing    afford    accurately    solution    mobile    disrupt    channels    planning    installed    proposition    time    qs    b2c    morphology    revenues    home    affordable    days    consuming    undergoing    commercialized    quality    inconvenient    habits    spermatozoa    image    chances    microfluidics    6m    swiss    that    switzerland    conception    carry    visits    automating    giving    exclusively    optics    total    compact    comfort    either    standardized    male    don    lab    device    market    automated    globally    secure    combines    reliability    men    semen    intends    15    manual    precision    sperm    sme    homes    types    privacy    b2b    sales    cheaply    removing    289    errors    serve    labs    classes    treatments    video    takes    biophos    feasibility    labour    fertility    217    hospitals    covers    smartphones    qualisperm    tests    infertility    motility    performed    20    clip    2027    validated    germany    concentration    industry    levels    annual   

Project "QS Mobile" data sheet

The following table provides information about the project.

Coordinator
BIOPHOS SA 

Organization address
address: PARC SCIENTIFIQUE EPFL PSE
city: LAUSANNE
postcode: 1015
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website http://www.biophos.ch
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-10-01   to  2018-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOPHOS SA CH (LAUSANNE) coordinator 50˙000.00

Map

 Project objective

QS Mobile is a novel clip-on device for smartphones for male sperm analysis. QS Mobile combines microfluidics technology, compact optics & advanced video image analysis to make sperm tests automated, removing the manual labour errors & providing precision & reliability levels comparable to labs. QS Mobile is the only solution that that covers all three types of sperm measurements required by WHO— concentration, different motility classes & spermatozoa morphology analysis. QS Mobile addresses the problem of time-consuming, inconvenient and not fully standardized tests of male infertility. Male infertility tests are currently performed exclusively in labs, and it takes several visits & several days to get a result. With QS Mobile male fertility tests can be carried out at home quickly, accurately & more cheaply than in the lab. It is targeted at men who are planning children, undergoing fertility treatments or interested to change their habits to increase their chances of conception. QS Mobile can also be used by hospitals that either don’t have or cannot afford a dedicated fertility lab. QS Mobile is developed by Biophos—a Swiss SME that commercialized QualiSperm—an industry-recognized advanced semen analysis technology installed in 15 labs in Germany & Switzerland & performing 20,000 sperm quality tests per year. With QS Mobile, Biophos intends to disrupt the market of male fertility tests by fully automating them and giving the affordable & reliable testing device to the men who need it, so that they can carry out the tests in privacy & comfort of their homes. By 2027 Biophos intends to serve 15-20% of total market with €217.2-289.6m annual revenues globally. In this phase 1 feasibility study Biophos will validated the B2C go-to-market approach & develop a value proposition for B2B market, develop sales & distribution channels & secure manufacturing partnerships.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "QS MOBILE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "QS MOBILE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

JUMPAIR (2018)

Decubitus Ulcers Diseases Diagnoses by means of Smart ICT Anti-Decubitus System based on known Ulcers Activity Biomarkers

Read More  

PRIDIKTIV (2017)

Pridiktiv - Exploring European expansion through 4 pilot studies

Read More